Loading…
Based on limited metadata, Sanit Technologies LLC (operating as Durisan) received an FDA Warning Letter on May 7, 2020 regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in this metadata. To understand the particular compliance issues cited, the complete Warning Letter would need to be reviewed.